CA
NZ
UK
AU
IND
US
Director Nachum Shamir filed a Form 4 with the SEC on November 12, 2026, reporting the exercise of Series A Warrants to acquire 16,336 ordinary shares of MediWound Ltd. (NASDAQ:MDWD) on November 10, 2026.
MediWound Ltd. Chief Executive Officer Ofer Gonen filed a Form 4 on November 12, 2026, disclosing the exercise of Series A Warrants to acquire 8,168 ordinary shares on November 10, 2026, at an exercise price of $13.475 per share.
Sally A. Washlow, Chief Executive Officer and Director of Orion Energy Systems, Inc., filed a Form 4 on November 12, 2026, disclosing an open-market purchase of common stock on November 11, 2026, along with previously reported derivative securities holdings.
Shabtai Adlersberg, President and CEO of AudioCodes Ltd, filed a Form 4 on November 12, 2026, disclosing three open-market purchases of ordinary shares made between November 9 and November 11, 2026.
David Chairman, SVP of R&D at Valens Semiconductor Ltd., filed a Form 4 on November 12, 2026, reporting the exercise of stock options and sale of ordinary shares on November 10 and November 11, 2026, pursuant to a Rule 10b5-1 trading plan.
Brian J. Caveney, EVP, President of BLS, CMO and CSO of Labcorp Holdings Inc., filed a Form 4 on November 12, 2026, disclosing a sale of common stock that occurred on November 10, 2026.
Steven L. Hoerter, Chairman, President and CEO of MBX Biosciences, Inc., filed a Form 4 on November 12, 2026, reporting the sale of 4,893 shares of common stock on November 10, 2026, to cover tax obligations arising from the vesting of restricted stock units.
Haine Yael Rozenberg, VP Finance of Valens Semiconductor Ltd., filed a Form 4 on November 12, 2026, reporting the sale of 625 ordinary shares on November 9, 2026, pursuant to a Rule 10b5-1 trading plan.
Thomas K. Equels, CEO and President of AIM ImmunoTech Inc., filed a Form 4 on November 12, 2026, disclosing an open-market purchase of 39,000 shares of common stock on November 10, 2026.
Seth Lederman, Chief Executive Officer and Director of Tonix Pharmaceuticals Holding Corp., filed a Form 4 on November 12, 2026, reporting the open-market purchase of 5,000 shares of common stock on November 11, 2026.
Please wait processing your request...